Haemonetics Corporation HAE
$ 73.12
2.29%
Quarterly report 2024-Q2
added 08-08-2024
Haemonetics Corporation Financial Ratios 2011-2024 | HAE
Annual Financial Ratios Haemonetics Corporation
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
39.9 | 36.7 | 98.2 | 30.8 | 80.5 | 84.3 | 90.3 | -83.8 | -25.3 | 128.5 | 46.6 | 52.8 | 27.1 | 22.0 |
P/S |
3.6 | 3.6 | 4.3 | 2.8 | 6.2 | 4.8 | 4.6 | 2.5 | 1.5 | 2.4 | 1.7 | 2.3 | 2.5 | 2.6 |
EPS |
2.3 | 2.3 | 0.8 | 1.6 | 1.5 | 1.1 | 0.9 | -0.5 | -1.1 | 0.3 | 0.7 | 0.8 | 1.3 | 1.6 |
EV (Enterprise Value) |
4.52 B | 3.95 B | 4 B | 2.26 B | 6.7 B | 5.08 B | 4.42 B | 2.56 B | 1.89 B | 2.67 B | 2.12 B | 2.56 B | 1.76 B | 1.71 B |
EBITDA per Share |
5.17 | 4.91 | 3.5 | 3.43 | 4.12 | 3.64 | 2.76 | 1.37 | 0.903 | 2.43 | 2.46 | 2.33 | 2.73 | 3.1 |
EV/EBITDA |
12.9 | 29.6 | 24.8 | 28.8 | 32.9 | 36.0 | 19.1 | 14.2 | 19.1 | 11.5 | 9.9 | |||
PEG |
4.55 | 2.59 | 3.71 | 0.85 | 1.91 | 4.15 | 0.34 | -1.57 | 0.06 | -2.49 | -4.8 | -1.21 | -1.74 | 0.56 |
P/B |
2.1 | 2.2 | 2.3 | 1.3 | 10.5 | 6.9 | 5.5 | 3.0 | 2.0 | 2.6 | 2.0 | 2.7 | 2.5 | 2.6 |
P/CF |
25.8 | 15.5 | 24.7 | 22.5 | 56.3 | 115.0 | 28.3 | 26.3 | 72.3 | 437.9 | 24.8 | 89.5 | 29.2 | 23.0 |
ROE % |
12.25 | 14.11 | 5.79 | 10.86 | 13.03 | 8.24 | 6.06 | -3.55 | -7.70 | 2.05 | 4.19 | 5.04 | 9.13 | 11.66 |
ROA % |
5.35 | 5.96 | 2.33 | 4.37 | 6.04 | 4.32 | 3.68 | -2.12 | -4.21 | 1.14 | 2.32 | 2.65 | 7.34 | 9.60 |
ROCE % |
17.18 | 19.08 | 10.77 | 12.27 | 10.42 | 8.04 | 6.59 | -1.89 | -3.88 | 3.13 | 3.65 | 4.40 | 11.37 | 15.25 |
Current Ratio |
- | - | - | - | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | 2.9 | 3.3 | 4.0 | 4.1 |
DSO |
53.8 | 52.9 | 52.7 | 61.4 | 61.0 | 69.8 | 61.1 | 62.9 | 63.1 | 58.5 | 64.0 | 69.6 | 67.9 | 68.6 |
DIO |
170.4 | 182.1 | 230.4 | 228.9 | 197.0 | 134.1 | 119.3 | 127.2 | 135.7 | 161.9 | 153.5 | 144.6 | 119.3 | 95.8 |
DPO |
40.6 | 40.3 | 40.7 | 39.0 | 37.0 | 43.7 | 41.0 | 30.9 | 28.8 | 37.1 | 41.6 | 39.3 | 36.1 | 32.1 |
Operating Cycle |
224.2 | 235.0 | 283.1 | 290.3 | 258.0 | 203.9 | 180.4 | 190.1 | 198.8 | 220.3 | 217.5 | 214.2 | 187.2 | 164.4 |
Cash Conversion Cycle |
183.6 | 194.7 | 242.4 | 251.3 | 221.1 | 160.2 | 139.4 | 159.2 | 170.0 | 183.2 | 175.9 | 175.0 | 151.1 | 132.3 |
All numbers in USD currency
Quarterly Financial Ratios Haemonetics Corporation
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.75 | - | 0.62 | 0.49 | 0.81 | - | 0.65 | 0.65 | 0.39 | - | - | 0.29 | 0.2 | -0.22 | 0.63 | 0.63 | 0.95 | 0.21 | 0.59 | 0.59 | 0.74 | -0.17 | 0.36 | 0.36 | 0.36 | 0.22 | -0.12 | 0.38 | 0.38 | 0.38 | 0.3 | 0.3 | 0.39 | -0.2 | -1.17 | -1.17 | 0.25 | -0.01 | 0.31 | 0.31 | 0.15 | -0.07 | 0.31 | 0.31 | 0.32 | -0.15 | 0.19 | 0.19 | 0.13 | 0.19 | 0.36 | 0.36 | 0.55 | 0.66 |
EBITDA per Share |
1.35 | - | 1.19 | 0.96 | 1.52 | - | 1.12 | 1.17 | 1.04 | - | - | 0.7 | 1.46 | -0.42 | 0.95 | 2.02 | 1.98 | 0.64 | 0.81 | 2.42 | 2.05 | 0.28 | 0.55 | 2.1 | 1.51 | 0.27 | 0.02 | 0.46 | 0.73 | 0.32 | 0.41 | 1.73 | 1.37 | -0.15 | -1.21 | 0.13 | 1.26 | 0.07 | 0.36 | 1.59 | 1.05 | -0.03 | 0.34 | 1.49 | 1.2 | -0.13 | 0.3 | 1.22 | 0.75 | 0.26 | 0.5 | 1.23 | 1.69 | 0.94 |
ROE % |
13.65 | 10.85 | 15.09 | 16.02 | 17.79 | 11.38 | 11.38 | 9.26 | 6.83 | 3.60 | 0.81 | 5.24 | 7.55 | 15.41 | 17.80 | 18.57 | 19.34 | 18.56 | 15.39 | 8.75 | 6.39 | 2.64 | 5.66 | 6.30 | 5.96 | 5.90 | 7.04 | 9.83 | 9.38 | 9.54 | 5.39 | -4.87 | -14.58 | -15.72 | -14.32 | -4.14 | 5.46 | 4.75 | 4.35 | 4.41 | 4.50 | 5.72 | 5.13 | 4.43 | 3.67 | 2.39 | 4.75 | 6.07 | 7.48 | 8.56 | 9.70 | 2.69 | 1.95 | 2.47 |
ROA % |
5.59 | 4.75 | 6.50 | 6.84 | 7.38 | 4.63 | 4.63 | 3.70 | 2.74 | 1.40 | 0.33 | 2.75 | 4.17 | 7.78 | 8.85 | 8.85 | 9.11 | 8.73 | 7.24 | 4.13 | 3.06 | 1.60 | 3.22 | 3.41 | 3.55 | 3.65 | 4.32 | 5.99 | 5.57 | 5.46 | 3.05 | -2.57 | -7.92 | -8.52 | -7.75 | -2.22 | 3.05 | 2.66 | 2.43 | 2.45 | 2.46 | 3.07 | 2.77 | 2.35 | 1.93 | 1.52 | 3.13 | 4.61 | 6.15 | 7.07 | 8.03 | 2.22 | 1.63 | 2.03 |
ROCE % |
18.09 | 15.03 | 20.61 | 21.31 | 23.77 | 15.98 | 15.98 | 13.91 | 11.01 | 10.84 | 4.21 | 9.83 | 11.94 | 16.92 | 21.97 | 23.47 | 24.96 | 24.68 | 20.51 | 18.18 | 15.47 | 10.66 | 14.81 | 10.14 | 8.77 | 7.20 | 7.55 | 10.17 | 9.98 | 11.29 | 7.96 | -3.30 | -14.00 | -15.05 | -13.52 | -2.83 | 7.27 | 6.37 | 5.74 | 5.68 | 5.69 | 7.20 | 6.54 | 6.43 | 6.23 | 4.51 | 7.15 | 8.72 | 10.42 | 11.72 | 13.41 | 3.73 | 2.61 | 3.48 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
55.4 | - | 52.4 | 50.4 | 52.2 | - | 52.7 | 48.8 | 53.4 | - | - | 52.1 | 25.4 | 55.6 | 54.8 | 53.6 | 66.7 | 78.4 | 61.2 | 59.9 | 62.9 | 67.5 | 60.7 | 57.7 | 57.1 | 58.2 | 56.6 | 59.8 | 65.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
195.5 | - | 169.9 | 177.7 | 173.7 | - | 158.9 | 174.1 | 218.5 | - | - | 252.4 | 124.5 | - | 229.8 | 227.8 | 248.4 | 226.7 | 173.8 | 162.6 | 151.3 | 135.2 | 111.4 | 113.5 | 118.3 | - | 121.7 | 129.3 | 134.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
42.5 | - | 39.5 | 48.9 | 45.0 | - | 39.0 | 39.0 | 44.5 | - | - | 36.6 | 19.1 | - | 35.0 | 37.0 | 43.6 | 44.5 | 38.2 | 41.2 | 45.1 | 46.9 | 40.4 | 41.3 | 42.5 | - | 30.9 | 30.6 | 31.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
250.9 | - | 222.3 | 228.0 | 225.9 | - | 211.6 | 222.8 | 271.9 | - | - | 304.5 | 149.9 | 55.6 | 284.5 | 281.5 | 315.1 | 305.1 | 235.0 | 222.4 | 214.2 | 202.7 | 172.1 | 171.3 | 175.4 | 58.2 | 178.3 | 189.1 | 200.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
208.4 | - | 182.8 | 179.1 | 180.9 | - | 172.6 | 183.8 | 227.4 | - | - | 267.9 | 130.8 | 55.6 | 249.6 | 244.4 | 271.5 | 260.5 | 196.7 | 181.2 | 169.1 | 155.8 | 131.8 | 130.0 | 132.9 | 58.2 | 147.4 | 158.4 | 168.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency